Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

BB-10010 has myelosuppressive and progenitor cell-mobilizing effects in humans

March 19, 1998

EntreMed's therapy for insufficient tissue oxygenation heading for clinic

March 18, 1998

European patent covers Bayer's new HMG-CoA reductase inhibitors

March 18, 1998

Lilly describes novel compounds for postmenopausal syndrome and related conditions

March 18, 1998

ARL-15849KF: a selective CCK-A agonist for the treatment of eating disorders

March 18, 1998

Spironolactone and Diane 35 may have synergistic effects in hirsutism

March 18, 1998

FDA advisory committee reaches a stand-off on orlistat recommendation

March 16, 1998

More antiobesity proteins emerge from Lilly research

March 16, 1998

Gene therapies for obesity revealed by Merck & Co., Baylor College of Medicine

March 16, 1998

The association between neuropathy and microcirculation in diabetic foot ulcers

March 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...